Cinque Partners’s Celgene Corp CELG Stock Holding History

Cinque Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,730	Closed	-$620K	–	58
2015 Q3	$620K	Hold	5,730	–	–	1.05%	39
2015 Q2	$663K	Buy	+5,730	New	+$655K	1.03%	38

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Cinque Partners's CELG Position: Q4 2015 in Review

Cinque Partners sold out of Celgene Corp (CELG) in Q4 2015, closing a stake of 5,730 shares — an estimated $620K sold.

Cinque Partners first reported a position in CELG in Q2 2015 and held it in 2 quarters. The position peaked at $663K in Q2 2015. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

Cinque Partners reported no remaining Celgene Corp position as of Q4 2015 after selling out during the quarter.
Cinque Partners sold 5,730 Celgene Corp shares in Q4 2015, an estimated $620K.
Cinque Partners first reported a position in Celgene Corp in Q2 2015 and held it in 2 quarters.
Cinque Partners's Celgene Corp position peaked at $663K in Q2 2015.
1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Cinque Partners's 13F filing for Q4 2015, filed 12 Feb 2016.